3 Top Growth Stocks That Turned $10,000 Into $100,000 in the Last 5 Years

Here’s why growth stocks such as Shopify and WELL Health remain solid long-term bets right now.

| More on:
Knowledge concept with quote written on wooden blocks

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Growth stocks have the potential to increase your wealth at an exponential rate over time. As these stocks have a high beta, they tend to outpace the broader markets in a bull run. Alternatively, when markets turn bearish, investors should also be ready for a significant pullback in their portfolio value.

Here, we look at three quality growth stocks in Shopify (TSX:SHOP)(NYSE:SHOP), WELL Health Technologies (TSX:WELL), and The Trade Desk (NASDAQ:TTD) that have already returned over 1,000% to investors in the last five years.

Shopify

Canada’s largest company in terms of market cap, Shopify stock has been up 2,900% in the last five years. In 2020, the e-commerce giant increased sales by 86% year over year. Its stellar top-line growth continued this year, evidenced by sales that were up 57% in Q2.

The ongoing pandemic served as a tailwind for companies part of the e-commerce space, allowing Shopify to onboard merchants on its platform at an accelerated clip. It now has 1.7 million merchants on the platform, at the end of Q2.

Shopify sales have risen at an annual rate of 65% in the last three years, allowing the company to report free cash flows of $507 million in the last year. Further, Shopify has estimated its total addressable market at $153 billion, providing the company with enough room to expand its top-line in the future.

WELL Health Technologies

A Canadian company that has focused on highly accretive acquisition to gain traction in the digital health segment, WELL Health Technologies is valued at a market cap of $1.11 billion. Analysts expect WELL Health sales to rise to $461 million in 2022, up from just $414,000 in 2017.

WELL Health has a majority stake in Circle Medical, a Silicon Valley-based company. Circle Medical aims to have a presence in 46 states by the end of the year and its revenue run rate exceeds $20 million right now. Further, its sales grew by 346% in the last month and rose by 275% in the last quarter on the back of a 191% growth in total active patients.

WELL Health stock is up 6,270% in the last five years, valuing the company at a market cap of $1.38 billion.

The Trade Desk

The final stock on my list is The Trade Desk, a company that operates in the digital advertising space. TTD uses bid factor technology to value ad impressions, allowing advertisers to better target their audience on a real-time basis.

In the second quarter of 2021, TTD sales more than doubled to US$280 million. Its adjusted EBITDA margin also improved to 42%, up from its pre-pandemic EBITDA margin of 36%. The company ended Q2 with 875 enterprise clients and confirmed the number of brands spending over US$1 million in connected television on its platform more than doubled year over year.

The Trade Desk also enjoys a high customer retention rate that has remained over 95% since 2014. It remains well poised to grow revenue at a fast pace in the upcoming decade on the back of aggressive international expansion.

TTD stock has risen by 2,500% in the last five years and is currently valued at a market cap of $36 billion.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Shopify and The Trade Desk. The Motley Fool recommends the following options: long January 2023 $1,140 calls on Shopify and short January 2023 $1,160 calls on Shopify.

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »